Maze Therapeutics, Inc. (MAZE) › Weighted Average Diluted SharesMaze Therapeutics, Inc. (MAZE) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2024-12-31: 2.73M2025-12-31: 42.98M42.98M2024-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-3142.98M+1474.0%2026-03-25From 2025-01-012024-12-312.73M—2026-03-25From 2024-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)